发明名称 COMBINATION THERAPY WITH GLATIRAMER ACETATE AND MITOXANTRONE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
摘要 <p>The subject invention provides a method of treating a subject afflicted with a form of multiple sclerosis comprising periodically administering to the subject an amount of glatiramer acetate and an amount of mitoxantrone, wherein the amounts when taken together are effective to alleviate a symptom of the form of multiple sclerosis in the subject so as to thereby treat the subject. The subject invention also provides a package comprising glatiramer acetate, mitoxantrone and instructions for use of the together to alleviate a symptom of a form of multiple sclerosis in a subject. Additionally, the subject invention provides a pharmaceutical composition comprising an amount of glatiramer acetate and an amount of mitoxantrone, wherein the amounts when taken together are effective to alleviate a symptom of a form of multiple sclerosis in a subject. The subject invention further provides a pharmaceutical combination comprising separate dosage forms of an amount of glatiramer acetate and an amount of mitoxantrone, which combination is useful to alleviate a symptom of a form of multiple sclerosis in a subject.</p>
申请公布号 SI1638589(T1) 申请公布日期 2014.07.31
申请号 SI20040032163T 申请日期 2004.05.14
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD. 发明人 VOLLMER TIMOTHY
分类号 A61K;A61K38/00 主分类号 A61K
代理机构 代理人
主权项
地址